New University of Michigan Tinnitus Discovery — Signal Timing

My 6 stages of grief.

:notworthy: :arghh: :banghead: :blackeye: :thankyousign: :mad:

What does she mean by no news as of yet :sneaky:

Guys, for our sakes, let's slowly back off this, and look at other trials.

I'm not going to lie, the fact they always kept stressing somatic tinnitus and not just chronic tinnitus always gave me doubts.

But hey at least she
replied so there must be some confidencez I guess...
Uhm... Somatic tinnitus is DEFINITELY chronic. I've had it for 30 years!
 
they didn't record any sessions at the conference.
What a surprise.

giphy.gif?cid=ecf05e47kcm6qtyrdfgr02r81yjwlkbd1v387i8hm18gd0ho&rid=giphy.gif
 
Hey @Warchop, thanks for your reply!

Perhaps she figured out some sort of "norm" to which her device brings auditory cortex to? (Or at least is aiming to)? I mean think about it, if there is "a" state of auditory cortex which is "normal" and "b" state which is "altered", perhaps she figured out a way to "bring it all down", i.e. regardless of the frequency on which tinnitus is perceived in?

This treatment is aimed to deal with tinnitus, not with underlying conditions (which is what we need at least for the very beginning) and perhaps that is exactly what she may have figured out?

Otherwise the only stuff will cure tinnitus for good is regeneration of hair cell/synapses. And for now some companies did figure out compounds that are capable of doing so, dosing and most important delivery is something these companies are struggling with.

P.S.

Honestly, if it would be like "hey take this pill daily, your hearing will regenerate slowly" I would sign up for that, but as far as where we are right now, only FX-322 was able to somewhat demonstrate ability to improve speech clarity which comes from 8 kHz+ on the frequency side. I hope that FX-345 can successfully penetrate down to 4 kHz and below so that actual hearing also would recover.

Hair cells / synapses recovered = fixed feedback to the brain = no tinnitus.
Based on the research I read, it boils down to cells that fire together, wire together. Cells that fire apart, wire apart. I think that by firing a shock before the tone in damaged auditory systems, it is supposed to suppress. I know with my stuff, I am able to achieve some measure of inhibition of my tinnitus.

Hopefully, FX-345 works down to 4 kHz... I always wondered what would happen if they mixed FX-345 with stem cells or PRP. I think the FX-345 will make it to market before bimodal. There are just too many permutations with bimodal.
 
So any results from this yet?
No. The last update from Dr. Shore is still the email she sent in April. From that, we know that their next steps are to 1) publish the data from their most recent phase 2, and 2) to move on with the process of getting FDA approval. What isn't exactly clear to me is when she'll start the FDA process: after submitting the study to a journal, or only after the study is published. Her email suggests the latter.

I think it's (somewhat?) safe to assume the results were positive. If they were negative, it wouldn't have made any sense for her to indicate that they would move on with getting FDA approval. Now, how positive the results were, and which patients benefited the most from it, is anybody's guess at this point.
 
No. The last update from Dr. Shore is still the email she sent in April. From that, we know that their next steps are to 1) publish the data from their most recent phase 2, and 2) to move on with the process of getting FDA approval. What isn't exactly clear to me is when she'll start the FDA process: after submitting the study to a journal, or only after the study is published. Her email suggests the latter.

I think it's (somewhat?) safe to assume the results were positive. If they were negative, it wouldn't have made any sense for her to indicate that they would move on with getting FDA approval. Now, how positive the results were, and which patients benefited the most from it, is anybody's guess at this point.
They are as positive as Neuromonics, Lenire and TRT.
 
On the other hand, improving hearing tremendously improves tinnitus for many people. So there is a great correlation that would be beneficial.
In my sample set of one, I had my hearing suddenly severely damaged instantly giving me severe tinnitus, after a half year or so my hearing remarkably healed and apparently returned to baseline (preexisting mild hearing loss ~30 dB >4 kHz) but the tinnitus didn't change one bit.

So in my little sample set of one, maybe underlying hearing loss was a precondition to me getting tinnitus, but reversing the triggering damage did nothing to undo the condition once established.
 
In my sample set of one, I had my hearing suddenly severely damaged instantly giving me severe tinnitus, after a half year or so my hearing remarkably healed and apparently returned to baseline (preexisting mild hearing loss ~30 dB >4 kHz) but the tinnitus didn't change one bit.

So in my little sample set of one, maybe underlying hearing loss was a precondition to me getting tinnitus, but reversing the triggering damage did nothing to undo the condition once established.
Did you have some form of tinnitus accompanying your mild hearing loss prior to tinnitus becoming severe?
 
In my sample set of one, I had my hearing suddenly severely damaged instantly giving me severe tinnitus, after a half year or so my hearing remarkably healed and apparently returned to baseline (preexisting mild hearing loss ~30 dB >4 kHz) but the tinnitus didn't change one bit.

So in my little sample set of one, maybe underlying hearing loss was a precondition to me getting tinnitus, but reversing the triggering damage did nothing to undo the condition once established.
That is a very real possibility that we all have to keep in mind when thinking about the potential benefits about regenerative drugs. On the other hand, like the person you're replying to said, even stuff as limited as hearing aids help some people.

In any case, this discussion is interesting but I'm not sure why we're even having it here, as Dr. Shore's work has nothing to do with regeneration.
 
Can anyone give me some expectations?

Will Dr. Shore's device be helpful for visual snow syndrome induced tinnitus? It's somatic so it would meet the criteria I guess, but I have no clue why I got it honestly, it's comorbid with TMJ/D, neck and ETD issues.
 
@AfroSnowman, you might be the only person ever to have their hearing improve!
I know a girl online whe lost her hearing for 2 years; it returned after 2 years and her tinnitus went away. They don't know how but I assume some kinda cochlear hydrops. I know that it can take a few years to resolve on its own.
 
When will we be updated? Does anyone know?
I seem to recall that Clinical Trial Results were supposed to be released in July.

I check her Site frequently, and all we still have is that notice posted on 09/07/21 (which, after nearly a year, states that it is "nearly market ready").

Our Chicago Tribune in their Health & Wellness Section had a lengthy article about this in 01/05/2018 (and about how it would be available soon), and my faith and other's in this has been tested more severely than Abraham's when God told him to slay his son.

I still submit that, like my migraines, the real treatments will have to come from drugs.
 
Unfortunately the trial is still active - so who knows!
Looking at the trial, those it will not work for are:

1) Tinnitus >1 year
2) >Moderate hearing loss
3) Any vestibular causes

It is also being tested for unilateral tinnitus, although that may just be because it is easier for subjects to rate loudness and pitch as the other ear does not impair this.

Completion date this month, so they couldn't have been analysing any data yet.

Good to see a large group of 400. Big difference to Lenire's 20 odd.
 
Looking at the trial, those it will not work for are:

1) Tinnitus >1 year
2) >Moderate hearing loss
3) Any vestibular causes

It is also being tested for unilateral tinnitus, although that may just be because it is easier for subjects to rate loudness and pitch as the other ear does not impair this.

Completion date this month, so they couldn't have been analysing any data yet.

Good to see a large group of 400. Big difference to Lenire's 20 odd.
I kindly disagree with 1), 2) and 3). We do not know for who the treatment works yet. As for the scope of the trial, you want to make sure your trial proves significance so you will set clear criteria to do so. Not being included in the criteria does not mean it does not work for you.

This device has only been tested on 20 people too. Based on those assumptions criteria were set for the next trial.
 
Looking at the trial, those it will not work for are:

1) Tinnitus >1 year
2) >Moderate hearing loss
3) Any vestibular causes
That is not what the trial description implies. Just because they aren't including a certain set of people as participants doesn't mean it won't work for them.
 
I kindly disagree with 1), 2) and 3). We do not know for who the treatment works yet. As for the scope of the trial, you want to make sure your trial proves significance so you will set clear criteria to do so. Not being included in the criteria does not mean it does not work for you.

This device has only been tested on 20 people too. Based on those assumptions criteria were set for the next trial.
I stand corrected and see your point. It just makes the trial more specific and allows for better results I guess. I just looked at who was included in Phase 2.

Similar to OTO-313 using <6 months, which does not mean it will not work for >6 months?
 
Looking at the trial, those it will not work for are:

1) Tinnitus >1 year
2) >Moderate hearing loss
3) Any vestibular causes

It is also being tested for unilateral tinnitus, although that may just be because it is easier for subjects to rate loudness and pitch as the other ear does not impair this.

Completion date this month, so they couldn't have been analysing any data yet.

Good to see a large group of 400. Big difference to Lenire's 20 odd.
@Nick47, when it comes to getting a drug or device through FDA approval, setting narrow trial parameters is key. If they took every instance of whatever they were trying to treat under the sun, nothing would get through. You still may be right, but we have a few anecdotes of people who had been suffering a lot longer than a year and experienced positive results in Phase 1. Let's hope it's that way for Phase 2 and beyond!
 
Just because they aren't including a certain set of people as participants doesn't mean it won't work for them.
There's no proof that standing on your head might not cure cancer yet, so why not try it?

Point being that the prove-a-negative approach is a backwards one. Those evaluating treatments want evidence that it will work for them, not go on a wing and a prayer.
 
Those evaluating treatments want evidence that it will work for them, not go on a wing and a prayer.
Yup, and for those who are outside of the acceptance criteria, this study isn't going to provide that specific evidence.

In addition to this, this study is also not evidence that it won't work for them. Absence of evidence isn't evidence of absence.

To give you a bit of insight as to why it still is useful: quite often, results do transfer over to different populations that aren't exactly the same as the population in the initial study. For example, we often start studies on rats because we see a reasonable amount of transferrable findings to humans. Just because you haven't been selected in the rat study doesn't mean you won't benefit from it.
 
Just because you haven't been selected in the rat study doesn't mean you won't benefit from it.
But given the well-established intractability of tinnitus how likely is it that those outside the acceptance criteria will benefit?

I mean, we already have studies suggesting it will work (i.e. Neuromod's) which turn out to not even be trustworthy.

Is it reasonable to leave a huge percentage of tinnitus sufferers guessing like this?
 

Log in or register to get the full forum benefits!

Register

Register on Tinnitus Talk for free!

Register Now